Companies: 10,795·Total market cap: $144.5T
Motus GI Holdings, Inc.

Motus GI Holdings, Inc.

MOTSOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$639
P/E Ratio
52W High$0.1
52W Low$0.00001

Motus GI Holdings, Inc. (MOTS) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

mots · pe ratio · data through Dec 31, 2023

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Motus GI Holdings, Inc. (MOTS) measures how much investors pay for each dollar of the company's trailing earnings. MOTS's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$15.89.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31

Forward P/E
N/A
FY2026 est. EPS $-8.55
Based on 1 analyst
EPS (TTM)
-$15.89
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Motus GI Holdings, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2015 – 2023 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Motus GI Holdings, Inc.
Motus GI Holdings, Inc.You
MOTS
$0MN/A-$15.89
Adhera Therapeutics, Inc.
Adhera Therapeutics, Inc.
ATRX
$0MN/A-$0.92
Bionovate Technologies Corp
Bionovate Technologies Corp
BIIO
$0MN/A-$0.01
CannAmerica Brands Corp.
CannAmerica Brands Corp.
CNNXF
$0MN/A-$0.06
GlobeImmune, Inc.
GlobeImmune, Inc.
GBIM
$0MN/A-$0.48
Hear AtLast Holdings, Inc.
Hear AtLast Holdings, Inc.
HRAL
$0MN/A-$0.00
IMRIS Inc.
IMRIS Inc.
IMRSQ
$0MN/A-$0.58

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 9 of 9 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2023-12-31Latest
FY2023
$-15.89
2022-12-31
FY2022
$-86.15
2021-12-31
FY2021
$-121.76
2020-12-31
FY2020
$-179.86
2019-12-31
FY2019
$-275.56
2018-12-31
FY2018
$-441.11
2017-12-31
FY2017
$-383.25
2016-12-31
FY2016
$-154.54
2015-12-31
FY2015
$-115.40

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Motus GI Holdings, Inc. (MOTS) measures how much investors pay for each dollar of the company's trailing earnings. MOTS's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$15.89.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$15.89 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

MOTS pe ratio · 6 questions

MOTS's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of -$15.89. Data sourced from Financial Modeling Prep via MOTS's SEC 10-K and 10-Q filings.

MOTS PE ratioWhat is MOTS PE ratioCurrent PE ratio of MOTSMOTS PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Motus GI Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08